Clinical Trial Update: Omega-3 Supplementation to ADHD Medication in Children [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omega-3 fatty acid supplementation in children taking ADHD medication. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Deficient Emotional Self-regulation

Drugs mentioned

• Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | Phase 4 | Status: COMPLETED | Results posted: 2017-06-29